Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Siemens-Betriebskrankenkasse | INDUSTRY |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The needle stimulation pad is a self-care device, which has been promoted for pain control and well-being. The aim of the study was to test the efficacy of the pad for chronic/recurrent low back pain treatment.
Patients with non-specific chronic or recurrent low back pain were selected from a large health insurance company database and advised to use the pad daily for two weeks; outcomes were assessed at baseline, weeks 2 and 14. Primary outcome measure was pain intensity at week 2; secondary outcome measures included the Oswestry disability index (ODI), health-related quality of life (SF-36), the fear avoidance beliefs questionnaire (FABQ), analgesic medication consumption and safety.
see above
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Needle stimulation pad | Experimental | a self-administered treatment with a mechanical needle stimulation pad, a mechanical device to be used for 30 minutes daily for 14 days. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Needle stimulation pad | Device |
|
|
| Measure | Description | Time Frame |
|---|---|---|
| Pain intensity | Visual analogue scale | day 14 |
| Measure | Description | Time Frame |
|---|---|---|
| Pain intensity | Visual analogue scale | Week 14 |
| Oswestry Low Back Pain Disability Index | Day 14 | |
| Oswestry Low Back Pain Disability Index |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Gustav Dobos, Professor | University of Duisburg-Essen | Principal Investigator |
Not provided
Not provided
| ID | Term |
|---|---|
| D017116 | Low Back Pain |
| ID | Term |
|---|---|
| D001416 | Back Pain |
| D010146 | Pain |
| D009461 | Neurologic Manifestations |
| D012816 | Signs and Symptoms |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Week 14 |
| Short Form 36 Health Survey Questionnaire (SF-36) | Day 14 |
| Short Form 36 Health Survey Questionnaire (SF-36) | Week 14 |
| Fear Avoidance Beliefs Questionnaire (FABQ) | Day 14 |
| Fear Avoidance Beliefs Questionnaire (FABQ) | Week 14 |
| Experiences with the intervention | Open question: "please indicate observed changes" | Day 14 |
| Medication use | Use of medication, daily log | Day 14 |
| Number of any adverse events | Day 14 |
| Pain intensity measured immediately after the application, visual analogue scale | 5 minutes |
| D013568 |
| Pathological Conditions, Signs and Symptoms |